Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
L01XA03
oxaliplatin
Manufacturer Information
GOLDPLUS UNIVERSAL PTE LTD
Qilu Pharmaceutical (Hainan) Co. Ltd